Cite
HARVARD Citation
Shoji, H. et al. (n.d.). Pro‐angiogenic TIE‐2‐expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma. International journal of cancer. 141 (5), pp. 1011-1017. [Online].